Hot topics and landmark studies from the 43rd annual meeting of the American Society of Clinical Oncology.
The results of several preclinical and clinical studies were reported by oncology professionals at the 43rd American Society of Clinical Oncology (ASCO) meeting, the largest international forum in which the latest achievements in cancer research are annually presented. The central theme this year was 'Translating Research into Practice', emphasizing the goal of forging stronger links between basic research and clinical practice. This review offers a critical, summarized selection of several of the foremost studies presented at the meeting. The focus is on the findings from randomized phase III trials that, in the authors' opinion, are most likely to have an immediate effect on clinical practice.
Puglisi
Fabio
F
Department of Oncology, University Hospital of Udine, Udine, Italy. puglisi.fabio@aoud.sanita.fvg.it
Aprile
Giuseppe
G
Fasola
Gianpiero
G
D017326:Clinical Trials, Phase III as Topic; D004358:Drug Therapy / Q000379:methods* / Q000639:trends; D006801:Humans; D008495:Medical Oncology / Q000379:methods* / Q000639:trends; D010818:Practice Patterns, Physicians' / Q000639:trends; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome